At the ASMS 2025 conference, Sciex showcased its latest mass spectrometry system, the ZenoTOF 8600, along with updates to its ...

Thermo Fisher Scientific launched two advanced mass spectrometers and emphasized its multi-omics strategy during the American ...

Seer Inc. (NASDAQ:SEER) announced a significant population-level study in collaboration with Korea University. This 3-year ...

Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...

A single, untargeted proteomics test for rare genetic diseases can analyze thousands of proteins from a 1ml sample of blood.

The acquisition of biocrates further enhances Bruker's MS-based metabolomics solutions. It also supports Bruker's expansion ...

First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics ...

At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the ...

This discovery-driven proteomics study of a pediatric population - including rare diseases - introduces a SNOMED CT-guided ...

SCIEX & Evosep expand access to standardized proteomics for pharma and biotech with new reseller agreement: Marlborough, Massachusetts Tuesday, June 3, 2025, 15:00 Hrs [IST] SCIEX ...

Momentum Biotechnologies ("Momentum"), a contract research organization specializing in mass spectrometry-based drug discovery and proteomics, announced today the appointment of two new members to its ...